Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis-Reference-Cited by-同舟云学术

Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis

Published:2021-11-16 Issue:1 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Piechotta Vanessa¹,Adams Anne²,Haque Madhuri¹,Scheckel Benjamin¹³,Kreuzberger Nina¹,Monsef Ina¹,Jordan Karin⁴,Kuhr Kathrin²,Skoetz Nicole⁵

Affiliation:

1. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

2. Institute of Medical Statistics and Computational Biology; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

3. Institute of Health Economics and Clinical Epidemiology; University of Cologne, Faculty of Medicine and University Hospital Cologne; Cologne Germany

4. Department of Medicine V; University of Heidelberg; Heidelberg Germany

5. Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference453 articles.

1. A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy;Aapro;Annals of Oncology,2006

2. Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy;Abdel-Malek;Journal of Egyptian National Cancer Institute,2017

3. Evaluation of the efficacy of aprepitant on the prevention of chemotherapy-induced nausea and vomiting and quality of life with functional living index emesis;Aksu;Balkan Medical Journal,2013

4. Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a Hoosier Oncology Group study;Albany;Journal of Clinical Oncology,2012

5. Brames M Picus J Yu M Johnston E Bottema B Williams C Phase III double-blind placebo-controlled study evaluating 5HT3 antagonist + dexamethasone +/- aprepitant in germ cell tumors receiving 5-day cisplatin chemotherapies Supportive Care in Cancer 2011 S140

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiemetic prophylaxis regimens in haematologic malignancies patients undergoing a hematopoietic stem cell transplantation. Which is the best standard of care? A systematic review;European Journal of Haematology;2024-07-29

2. Adverse drug events associated with fluorouracil use in patients with metastatic colorectal cancer: a real-world pharmacovigilance study based on the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-07-23

3. Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis;Clinical Breast Cancer;2024-07

4. The efficacy and safety of Xiao-Ban-Xia-Tang in the treatment of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis;Frontiers in Pharmacology;2024-06-12

5. Electrical acupoint stimulation for the treatment of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis;Heliyon;2024-05